1. Home
  2. ACHL

as 06-20-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

Founded: 2016 Country:
United Kingdom
United Kingdom
Employees: N/A City: N/A
Market Cap: 38.2M IPO Year: 2021
Target Price: $2.83 AVG Volume (30 days): 72.8K
Analyst Decision: Hold Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.60 EPS Growth: N/A
52 Week Low/High: $0.74 - $1.76 Next Earning Date: 08-02-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

ACHL Daily Stock ML Predictions

Share on Social Networks: